Picture of Alimera Sciences logo

ALIM — Alimera Sciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Alimera Sciences Inc expected to post a loss of 69  cents a share - Earnings Preview

* Alimera Sciences Inc  ALIM.OQ   ALIM.O  is expected
to show a
rise in quarterly revenue when it reports  results on April 26
(estimated). 
    * The Alpharetta Georgia-based  company is expected to
report  a
15.0% increase in revenue to $12.9 million from $11.21 million a
year ago, according to the mean estimate from 3 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Alimera Sciences
Inc is
for a loss of 69 cents per share. For the same quarter last
year, the company reported a loss of 63 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Alimera
Sciences
Inc is $11​, above​ its last closing price of $5.85. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.41       -0.42      -0.59     Missed  -40.5
 Sep. 30 2021  -0.52       -0.52      -0.60     Missed  -14.3
 Jun. 30 2021  1.05        1.06       0.72      Missed  -32.1​
 Mar. 31 2021  -0.52       -0.54      -0.63     Missed  -16.7
 ​​Dec.        -0.04       -0.04      -0.18     Missed  -315.4
 31 2020                                                
 Sep. 30 2020  -0.44       -0.44      -0.12     Beat    72.9​
 Jun. 30 2020  -1.09       -1.61      -0.51     Beat    68.4
 Mar. 31 2020  -0.44       -0.43      -0.24     Beat    44.5
 This summary was machine generated April 22 at 12:01 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Alimera Sciences

See all news